Literature DB >> 7857911

Consumption of diets containing raw soya beans (Glycine max), kidney beans (Phaseolus vulgaris), cowpeas (Vigna unguiculata) or lupin seeds (Lupinus angustifolius) by rats for up to 700 days: effects on body composition and organ weights.

G Grant1, P M Dorward, W C Buchan, J C Armour, A Pusztai.   

Abstract

Feeding trials have been done with rats to assess the effects of long-term (700 d) consumption of diets based on raw cowpeas (Vigna unguiculata; moderate Bowman-Birk inhibitor content, low lectin content), lupin seeds (Lupinus angustifolius; low lectin and protease inhibitor content) or soya beans (Glycine max; high Kunitz inhibitor content, moderate Bowman-Birk inhibitor content, moderate lectin content) or diets containing low levels of raw kidney bean (Phaseolus vulgaris; high lectin content, low Bowman-Birk inhibitor content) on body weight and composition and organ weights. All the legume-based diets reduced feed conversion efficiency and growth rates during the initial 250 d. However, after 250 d the weight gains by rats given legume-based diets were similar to those of controls given the same daily feed intake. Long-term consumption of diets containing low levels of kidney bean significantly altered body composition of rats. The levels of lipid in the body were significantly reduced. As a result, carcasses of these rats contained a higher proportion of muscle/protein than did controls. Small-intestine relative weight was increased by short- and long-term consumption of the kidney-bean-based diet. However, the increase in relative pancreatic weight observed at 30 d did not persist long term. None of the other legume-based diets caused any significant changes in body composition. However, long-term exposure to a soya-bean- or cowpea-based diet induced an extensive increase in the relative and absolute weights of the pancreas and caused an increase in the incidence of macroscopic pancreatic nodules and possibly pancreatic neoplasia. Long-term consumption of the cowpea-, kidney-bean-, lupin-seed- or soya-bean-based diets by rats resulted in a significant increase in the relative weight of the caecum and colon.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7857911

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  6 in total

1.  In vivo degradation and stimulating effect of phaseolin on nitrogen secretion in rats.

Authors:  L G Santoro; G Grant; A Pusztai
Journal:  Plant Foods Hum Nutr       Date:  1999       Impact factor: 3.921

2.  Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism.

Authors:  Mauro Am Carai; Noemi Fantini; Barbara Loi; Giancarlo Colombo; Antonella Riva; Paolo Morazzoni
Journal:  Diabetes Metab Syndr Obes       Date:  2009-09-07       Impact factor: 3.168

3.  Lectin Digestibility and Stability of Elderberry Antioxidants to Heat Treatment In Vitro.

Authors:  Pilar Jiménez; Patricia Cabrero; Damian Cordoba-Diaz; Manuel Cordoba-Diaz; Manuel Garrosa; Tomás Girbés
Journal:  Molecules       Date:  2017-01-06       Impact factor: 4.411

Review 4.  Protease inhibitors and their peptidomimetic derivatives as potential drugs.

Authors:  Georgie Fear; Slavko Komarnytsky; Ilya Raskin
Journal:  Pharmacol Ther       Date:  2006-09-22       Impact factor: 12.310

Review 5.  Common bean (Phaseolus vulgaris L.) α-amylase inhibitors as safe nutraceutical strategy against diabetes and obesity: An update review.

Authors:  Stefania Peddio; Alessandra Padiglia; Faustina B Cannea; Roberto Crnjar; Wissam Zam; Javad Sharifi-Rad; Antonio Rescigno; Paolo Zucca
Journal:  Phytother Res       Date:  2022-04-29       Impact factor: 6.388

6.  A Phaseolus vulgaris Extract Reduces Cue-Induced Reinstatement of Chocolate Seeking in Rats.

Authors:  Irene Lorrai; Valentina Piga; Mauro A M Carai; Antonella Riva; Paolo Morazzoni; Gian Luigi Gessa; Giancarlo Colombo; Paola Maccioni
Journal:  Front Pharmacol       Date:  2016-04-26       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.